((自动化翻译由路透提供，请见免责声明 )) (第3段增加了细节，第4段增加了背景资料)
路透10月21日 - 百特国际 周一表示，该公司的目标是在今年年底前将能够开始使用其腹膜透析液的新病人数量恢复到飓风海伦肆虐前的 水平。
此前，该公司曾要求医生和医疗保健专业人员将新透析患者限制在 18 岁以下，以努力解决供应问题。
百特公司还表示，它已将某些儿童医院的拨款增加到 100%，以确保为最脆弱的病人提供稳定的供应。
上个月，这家医疗设备制造商报告说，其位于北卡罗来纳州的 NorthCove 工厂 受到了与飓风有关的洪水的影响，导致暂时关闭。这一中断造成了包括生理盐水和透析液在内的静脉注射产品在美国的短缺。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.